3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Cytokine Release Syndrome
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Thymoma
1
Thymic epithelial tumor
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Neurotoxicity Syndromes
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Lymphoproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lymphoma
1
Lymphohistiocytosis, Hemophagocytic
1
Lymphatic Diseases
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Hodgkin Disease
1
Epstein-Barr Virus Infections
1
Colorectal Neoplasms
1
Interventions
Cyclophosphamide
7
venetoclax
5
fludarabine phosphate
5
tagraxofusp
3
fludarabine
3
Whole-Body Irradiation
3
Thiotepa
3
Mycophenolic Acid
3
Methotrexate
3
merphos
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Tacrolimus
2
Specimen Handling
2
Rituximab
2
Dexamethasone
2
Cytarabine
2
Cyclosporins
2
Cyclosporine
2
Calcium Dobesilate
2
prednylidene
1
exifone
1
deltacortene
1
azathiopurine
1
X-Rays
1
Vincristine
1
Sirolimus
1
Ranitidine
1
Prednisone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Blastic Plasmacytoid Dendritic Cell Neoplasm
×
AP 1903 reagent
×
1 year
×
Clear all
No trials found.